Tristel plc
("Tristel" or the "Company")
Director/PDMR Shareholding
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Liz Dixon, Chief Financial Officer of the Company, sold 50,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 397.5 pence per Ordinary Share.
As a result, Liz Dixon's beneficial interest in the Company is 150,000 Ordinary Shares, representing 0.31 per cent. of the total issued share capital.
For further information please contact:
Tristel plc |
Via Walbrook PR |
|
|
Matt Sassone, Chief Executive Officer |
||
|
Liz Dixon, Chief Financial Officer |
|
|
|
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
|
|
Paul McManus |
Mob: 07980 541 893 |
|
|
Charlotte Edgar |
Mob: 07584 391 303 |
|
|
|
|
|
|
Cavendish Capital Markets Limited |
Tel: 020 7220 0500 |
|
|
Geoff Nash/ Camilla Hume / Trisyia Jamaludin (Corporate Finance) |
|
|
|
Sunila de Silva (Corporate Broking) Louise Talbot (Sales) |
|
|
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Elizabeth Dixon |
||||
|
2. |
Reason for the Notification. |
|||||
|
a) |
Position/status |
Chief Financial Officer |
||||
|
b) |
Initial notification/Amendment |
|
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Tristel plc |
||||
|
b) |
LEI |
2138009DZ4LH9CZGF662 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the Financial instrument, type of instrument |
|
||||
|
Identification code |
GB00B07RVT99 |
|||||
|
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information: - Aggregated volume - Aggregated price
|
Single transaction as in 4 c) above |
||||
|
e) |
Date of the transaction |
19 September 2024 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
